The Buckle’s growth appears limited despite operational gains. Learn why BKE stock is at a cyclical high and why I’m moving it to Hold.

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth watching before buying.

Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...

The Guggenheim Strategic Opportunities Fund has boasted impressive returns, beating out the S&P 500 since my first recommendation. Learn more on GOF CEF here.

Amalgamated Financial Corp. ( NASDAQ: AMAL) Q4 2024 Earnings Conference Call January 23, 2025 11:00 AM ET Jason Darby - Chief Financial Officer Priscilla Sims Brown - President & Chief Executive ...

The U.S. equity market has been a standout performer compared to its global counterparts. However, there may be opportunities to be found overseas. Click to read.

Indexed Trust ETF outperformed energy in 2024. Learn why GSG could rise further in 2025 due to inflation and global economic trends.

GE Aerospace posts strong Q3 results, announces $7B stock buyback; shares soar. American Airlines expects a significant Q4 loss; EA cuts 2025 net bookings guidance.

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to deliver. Learn more on TGTX stock here.

Arrow Electronics faces a cautious outlook with mixed earnings expectations. Learn why ARW stock is a hold until the full ...

Match Group is a strong investment with undervalued potential, first-mover advantages, and long-term growth prospects. Click here to read why MTCH is a Buy.

Three key questions are lurking for bonds related to inflation, tariffs and the US government’s growing budget deficit. Click ...